2016
DOI: 10.1007/s00238-016-1189-3
|View full text |Cite
|
Sign up to set email alerts
|

Enhanced recovery after surgery (ERAS) pathways in autologous breast reconstruction: a systematic review

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 14 publications
(17 citation statements)
references
References 40 publications
0
17
0
Order By: Relevance
“…Two other recent reviews compared ERAS/FTS with conventional programs in patients undergoing autologous breast reconstruction surgery. However, Gnaneswaran et al (11) only included three studies, an inadequate number, and only four outcome measures, which was insufficient to assess the safety and effectiveness of the ERAS program for breast reconstruction surgery. Offodile et al (13) included six observational studies, three-fifths the number of studies our review included.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Two other recent reviews compared ERAS/FTS with conventional programs in patients undergoing autologous breast reconstruction surgery. However, Gnaneswaran et al (11) only included three studies, an inadequate number, and only four outcome measures, which was insufficient to assess the safety and effectiveness of the ERAS program for breast reconstruction surgery. Offodile et al (13) included six observational studies, three-fifths the number of studies our review included.…”
Section: Discussionmentioning
confidence: 99%
“…One systematic review of breast reconstruction published in 2016 also analyzed LOS and postoperative complications (11); in this article, the number of studies included was inadequate at only three. Another study of microsurgical breast reconstruction published in 2017 was the minutes taken during a meeting (12).…”
Section: Introductionmentioning
confidence: 99%
“…All of the 55 articles investigated the impact of ERAS/FTS on clinical outcomes compared with conventional care mode involved in colorectal surgery (n = 13), [ 3 , 31 42 ] liver surgery (n = 7), [ 43 49 ] gastric surgery (n = 7), [ 22 , 50 55 ] orthopedic surgery (n = 3), [ 56 58 ] bariatric surgery (n = 3), [ 59 61 ] urology surgery (n = 3), [ 62 – 64 ] breast surgery (n = 3), [ 65 67 ] esophageal surgery (n = 3), [ 68 70 ] pancreatic surgery (n = 3) [ 71 73 ] and other surgeries (n = 10) [ 4 , 74 82 ] including gynecologic surgery, [ 74 ] abdominal aortic aneurysm repair surgery, [ 76 ] lung surgery [ 77 ] and vascular operations. [ 79 ] The most clinical results were measured in the meta-analyses are length of hospital stay (LOS)/post-operative hospital stay (PLOS) (n = 47), cost (n = 16), mortality (n = 30), morbidity (n = 54), readmission (n = 42), reoperation (n = 8) and other secondary outcomes.…”
Section: Resultsmentioning
confidence: 99%
“…ERAS pathways across surgical disciplines have been shown to expedite recovery time, reduce LOS, and reduce cost . On literature review of ERAS pathways for breast reconstruction, three studies with a combined population of 268 fast‐tracked patients each performed comparative evaluation between patients undergoing an ERAS pathway, and traditional care after deep inferior epigastric perforator and transverse rectus abdominis myocutaneous flap reconstruction .…”
Section: Introductionmentioning
confidence: 99%